Metastasis-associated Protein 2 Promotes the Metastasis of Non-small Cell Lung Carcinoma by Regulating the ERK/AKT and VEGF Signaling Pathways

Overview

Journal Mol Med Rep

Specialty Molecular Biology

Date 2018 Feb 3

PMID 29393472

Citations 3

Authors

Bin Zhang

Feng Tao

Hao Zhang

Affiliations

Soon will be listed here.

Abstract

Non-small cell lung carcinoma (NSCLC) is the most common cause of cancer‑associated mortality in the world and accounts for ~85% of human lung cancers. Metastasis‑associated protein 2 (MTA2) is a component of the histone deacetylase complex and serves a role in tumor progression; however, the mechanism through which MTA2 is involved in the progression of NSCLC remains unclear. The aim of the present study was to investigate the expression and function of MTA2 and the MTA2‑mediated signaling pathway in NSCLC cells. Expression of MTA2 and its target genes was analyzed in MTA2‑overexpressing and anti‑MTA2 antibody (AbMTA2)‑treated NSCLC cells, as well as growth, migration, invasion and apoptotic‑resistance. The inhibitory effects on tumor formation were analyzed using AbMTA2‑treated NSCLC cells and in a mouse model. Histological assessment was conducted to analyze the expressions levels of extracellular signal‑regulated kinase (ERK), RAC‑α serine/threonine protein kinase (AKT) and vascular endothelial growth factor (VEGF) in experimental tumors. Results of the present study demonstrated that MTA2 was overexpressed in NSCLC cells. The growth, migration and invasion of NSCLC cells were markedly inhibited by AbMTA2. In addition, it was observed that the ERK/AKT and VEGF signaling pathways were both upregulated in MTA2‑overexpressing NSCLC cells, and downregulated following silencing of MTA2 activation. ERK and AKT phosphorylation levels were downregulated in NSCLC cells and tumors following MTA2 silencing. The in vivo study demonstrated that tumor growth was markedly inhibited following siRNA‑MTA2 treatment. In conclusion, the results of the present study suggested that MTA2 silencing may significantly inhibit the growth and aggressiveness of NSCLC cells. Results from the present study indicated that the mechanism underlying the MTA2‑mediated invasive potential of NSCLC cells involved the ERK/AKT and VEGF signaling pathways, which may be a potential therapeutic target for the treatment of NSCLC.

Citing Articles

A Novel Hypoxia-Related Gene Signature with Strong Predicting Ability in Non-Small-Cell Lung Cancer Identified by Comprehensive Profiling.

Yang H, Wang Z, Gong L, Huang G, Chen D, Li X Int J Genomics. 2022; 2022:8594658.

PMID: 35634481 PMC: 9135579. DOI: 10.1155/2022/8594658.

An isoflavone derivative potently inhibits the angiogenesis and progression of triple-negative breast cancer by targeting the MTA2/SerRS/VEGFA pathway.

Zhang X, Zou G, Li X, Wang L, Xie T, Zhao J Cancer Biol Med. 2020; 17(3):693-706.

PMID: 32944400 PMC: 7476100. DOI: 10.20892/j.issn.2095-3941.2020.0010.

Metastasis-associated protein 2 regulates human hepatocellular carcinoma metastasis progression through modulating p38MAPK/MMP2 pathways.

Hsu W, Chiou H, Lin C, Kao S, Lee H, Liu C J Cancer. 2019; 10(26):6716-6725.

PMID: 31777601 PMC: 6856896. DOI: 10.7150/jca.35626.

References

Trinh X, Tjalma W, Vermeulen P, Van den Eynden G, Van der Auwera I, Van Laere S . The VEGF pathway and the AKT/mTOR/p70S6K1 signalling pathway in human epithelial ovarian cancer. Br J Cancer. 2009; 100(6):971-8. PMC: 2661789. DOI: 10.1038/sj.bjc.6604921. View

Chen C, Fei Z, Chen L, Bai P, Lin X, Pan J . Will weight loss cause significant dosimetric changes of target volumes and organs at risk in nasopharyngeal carcinoma treated with intensity-modulated radiation therapy?. Med Dosim. 2013; 39(1):34-7. DOI: 10.1016/j.meddos.2013.09.002. View

Ibrahim M, Parry S, Wilkinson D, Bilbe N, Allen D, Forrest S . ALK Immunohistochemistry in NSCLC: Discordant Staining Can Impact Patient Treatment Regimen. J Thorac Oncol. 2016; 11(12):2241-2247. DOI: 10.1016/j.jtho.2016.07.012. View

Zhuang T, Djemil T, Qi P, Magnelli A, Stephans K, Videtic G . Dose calculation differences between Monte Carlo and pencil beam depend on the tumor locations and volumes for lung stereotactic body radiation therapy. J Appl Clin Med Phys. 2013; 14(2):4011. PMC: 5714368. DOI: 10.1120/jacmp.v14i2.4011. View

Shi S, Zhang P, Cheng Q, Wu J, Cui J, Zheng Y . Immunohistochemistry of deparaffinised sections using antigen retrieval with microwave combined pressure cooking versus immunofluorescence in the assessment of human renal biopsies. J Clin Pathol. 2013; 66(5):374-80. DOI: 10.1136/jclinpath-2012-201125. View

Setton J, Wolden S, Caria N, Lee N . Definitive treatment of metastatic nasopharyngeal carcinoma: Report of 5 cases with review of literature. Head Neck. 2012; 34(5):753-7. DOI: 10.1002/hed.21608. View

Passaro A, Spitaleri G, de Marinis F . First-line treatment in NSCLC harboring EGFR common mutations: EGFR TKI in monotherapy or in combination with anti-VEGF?. Expert Rev Anticancer Ther. 2016; 16(8):799-801. DOI: 10.1080/14737140.2016.1210007. View

Charvat H, Sasazuki S, Inoue M, Iwasaki M, Sawada N, Shimazu T . Prediction of the 10-year probability of gastric cancer occurrence in the Japanese population: the JPHC study cohort II. Int J Cancer. 2015; 138(2):320-31. DOI: 10.1002/ijc.29705. View

Zhang H, Zhu X, Li N, Li D, Sha Z, Zheng X . miR-125a-3p targets MTA1 to suppress NSCLC cell proliferation, migration, and invasion. Acta Biochim Biophys Sin (Shanghai). 2015; 47(7):496-503. DOI: 10.1093/abbs/gmv039. View

10.

Beck J . Potential role for mammalian target of rapamycin inhibitors as first-line therapy in hormone receptor-positive advanced breast cancer. Onco Targets Ther. 2015; 8:3629-38. PMC: 4676614. DOI: 10.2147/OTT.S88037. View

11.

Li Y, Xie G, Pan Z . [Advancement biological target therapy of nasopharyngeal carcinoma]. Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2015; 29(7):671-3. View

12.

Moro-Sibilot D, Smit E, de Castro Carpeno J, Lesniewski-Kmak K, Aerts J, Villatoro R . Non-small cell lung cancer patients with brain metastases treated with first-line platinum-doublet chemotherapy: Analysis from the European FRAME study. Lung Cancer. 2016; 90(3):427-32. DOI: 10.1016/j.lungcan.2015.11.011. View

13.

Liu S, Han Y, Zhang Y, Xie C, Wang E, Miao Y . Expression of metastasis-associated protein 2 (MTA2) might predict proliferation in non-small cell lung cancer. Target Oncol. 2012; 7(2):135-43. DOI: 10.1007/s11523-012-0215-z. View

14.

Jiang S, Zhao J, Wang M, Huo Z, Zhang J, Zhong W . Small-Cell Lung Cancer Transformation in Patients With Pulmonary Adenocarcinoma: A Case Report and Review of Literature. Medicine (Baltimore). 2016; 95(6):e2752. PMC: 4753919. DOI: 10.1097/MD.0000000000002752. View

15.

Abar L, Vieira A, Aune D, Stevens C, Vingeliene S, Navarro Rosenblatt D . Blood concentrations of carotenoids and retinol and lung cancer risk: an update of the WCRF-AICR systematic review of published prospective studies. Cancer Med. 2016; 5(8):2069-83. PMC: 4971935. DOI: 10.1002/cam4.676. View

16.

Nakamura K, Nozawa K, Aoyagi Y, Ishihara S, Matsuda K, Fukushima J . A case report of thyroid gland metastasis associated with lung metastasis from colon cancer. Tumori. 2011; 97(2):229-32. DOI: 10.1177/030089161109700217. View

17.

Wang Y, Jia H, Lin H, Tan X, Du Z, Chen H . Metastasis-associated gene, mag-1 improves tumour microenvironmental adaptation and potentiates tumour metastasis. J Cell Mol Med. 2012; 16(12):3037-51. PMC: 4393732. DOI: 10.1111/j.1582-4934.2012.01633.x. View

18.

Kular H, Mudambi L, Lazarus D, Cornwell L, Zhu A, Casal R . Safety and feasibility of prolonged bronchoscopy involving diagnosis of lung cancer, systematic nodal staging, and fiducial marker placement in a high-risk population. J Thorac Dis. 2016; 8(6):1132-8. PMC: 4886017. DOI: 10.21037/jtd.2016.04.06. View

19.

Livak K, Schmittgen T . Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2002; 25(4):402-8. DOI: 10.1006/meth.2001.1262. View

20.

Uhara H . [Molecular target therapies for skin cancers]. Nihon Rinsho. 2015; 73(8):1391-7. View